A Single Arm Multicenter Real-world Observational Study of Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer
Latest Information Update: 28 Feb 2022
At a glance
- Drugs Pyrotinib (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer; Brain metastases; HER2 positive breast cancer
- Focus Therapeutic Use
Most Recent Events
- 28 Feb 2022 New trial record